scispace - formally typeset
S

Stanley Nattel

Researcher at Montreal Heart Institute

Publications -  802
Citations -  72437

Stanley Nattel is an academic researcher from Montreal Heart Institute. The author has contributed to research in topics: Atrial fibrillation & Heart failure. The author has an hindex of 132, co-authored 778 publications receiving 65700 citations. Previous affiliations of Stanley Nattel include Mayo Clinic & Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Transmural expression of transient outward potassium current subunits in normal and failing canine and human hearts

TL;DR: It is concluded that both Kv 4.3 and KChIP2 may contribute to epicardial–endocardial gradients in Ito, and that Ito down‐regulation in human and canine CHF appears due primarily to changes in Kv4.3.
Journal ArticleDOI

Lone Atrial Fibrillation Does it Exist

TL;DR: There are no apparently unique mechanisms for AF in patients categorized as having lone AF and the term "lone AF" is not invariably useful in making treatment decisions, and other tools for doing so have been more thoroughly and carefully validated.
Journal ArticleDOI

Protein Kinase C Activates ATP-Sensitive K+ Current in Human and Rabbit Ventricular Myocytes

TL;DR: It is concluded that PKC activates I(KATP) in rabbit and human ventricular myocytes by reducing channel sensitivity to intracellular ATP and has potentially important implications for understanding the mechanisms of ischemic preconditioning.
Journal ArticleDOI

Transient outward and delayed rectifier currents in canine atrium: properties and role of isolation methods

TL;DR: It is concluded that Ito1, Ito2, and both components of IK are present in dog atrium, IK is much more sensitive to the isolation method than Ito3, and the properties of two important repolarizing currents (Ito1 and IK) previously described in human atrium are similar to those inDog atrium.
Journal ArticleDOI

Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure

TL;DR: It is shown that targeted ablation of the integrin-linked kinase (ILK) expression results in spontaneous cardiomyopathy and heart failure by 6 wk of age, suggesting that ILK plays a central role in protecting the mammalian heart against cardiomeopathy and failure.